NRG
37
-13
EQR
44
5
RIG
37
-9
PNR
48
-26
IVZ
68
2
T
29
-27
USB
64
-12
MCK
64
-2
AAL
51
-6
TAP
41
-10
STI
5
-41
LB
33
11
INTU
54
-9
APD
50
3
DE
46
-3
PAYX
36
-26
RRC
62
-16
COP
44
4
PPG
54
-8
SIG
44
-28
NRG
37
-13
EQR
44
5
RIG
37
-9
PNR
48
-26
IVZ
68
2
T
29
-27
USB
64
-12
MCK
64
-2
AAL
51
-6
TAP
41
-10
STI
5
-41
LB
33
11
INTU
54
-9
APD
50
3
DE
46
-3
PAYX
36
-26
RRC
62
-16
COP
44
4
PPG
54
-8
SIG
44
-28
Financhill
Back

Nuveen Pennsylvania Quality Municipal Income Fund Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
25

NQP
Nuveen Pennsylvania Quality Municipal Income Fund

Last Price:
$12.02
Seasonality Move:
1.87%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$65.70
Seasonality Move:
25.93%
Sell
25
Nuveen Pennsylvania Quality Municipal Income Fund (NQP) is a Sell

Is Nuveen Pennsylvania Quality Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen Pennsylvania Quality Municipal Income Fund [NQP] share price is $12.03. The Score for NQP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NQP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NQP Stock Price Chart

What is Nuveen Pennsylvania Quality Municipal Income Fund's stock price today?

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $67.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

NQP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 43.89 Sell
Chaikin Money Flow: 104200 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.07 - 12.17) Sell
Bollinger Bands (100): (11.15 - 12.19) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.86 Sell
Relative Strength Index (14 RSI): 33.87 Sell
Chaikin Money Flow: -124010 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.34 - 86.38) Sell
Bollinger Bands (100): (44.81 - 88.99) Buy

NQP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 12.11 Sell
50-day SMA: 12.09 Sell
200-day SMA: 11.41 Buy
8-day EMA: 12.07 Sell
20-day EMA: 12.09 Sell
50-day EMA: 12 Buy
200-day EMA: 11.63 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.5 Sell
20-day SMA: 80.22 Sell
50-day SMA: 82.77 Sell
200-day SMA: 51.96 Buy
8-day EMA: 74.03 Sell
20-day EMA: 77.79 Sell
50-day EMA: 77.58 Sell
200-day EMA: 56.47 Buy

Nuveen Pennsylvania Quality Municipal Income Fund Earnings Growth & NQP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Nuveen Pennsylvania Quality Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):